Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 145.23
   
  • Change Today:
    $-0.36
  • 52 Week High: $155.80
  • 52 Week Low: $110.56
  • Currency: US Dollars
  • Shares Issued: 1,241.00m
  • Volume: 1,098,756
  • Market Cap: $180,230m
  • RiskGrade: 120
  • Beta: 0.01

Latest ShareCast News

Gilead Sciences to buy German biotech group Tubulis for up to $5bn

By Michele Maatouk

Date: Tuesday 07 Apr 2026

(Sharecast News) - California-based Gilead Sciences said on Tuesday that it has agreed to buy German clinical stage biotechnology group Tubulis for up to $5bn.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 145.23
Change Today $ -0.36
% Change -0.25 %
52 Week High $155.80
52 Week Low $110.56
Volume 1,098,756
Shares Issued 1,241.00m
Market Cap $180,230m
Beta 0.01
RiskGrade 120

What The Brokers Say

Strong Buy 8
Buy 15
Neutral 5
Sell 1
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 15-Sep-2026

Time Volume / Share Price
11:24 100 @ $145.23
11:23 100 @ $145.23
11:23 100 @ $145.22
11:23 100 @ $145.22
11:23 100 @ $145.22

Top of Page